Susquehanna International Group, LLP Electro Core, Inc. Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.21 - $0.36 $4,424 - $7,584	21,068 New	21,068 $5,000
Q2 2022 Aug 15, 2022	SELL	$0.27 - $0.61 $22,895 - $51,726	-84,798 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.5 - $0.88 $31,149 - $54,823	62,299 Added 276.9%	84,798 $50,000
Q4 2021 Feb 14, 2022	BUY	$0.58 - $1.09 $13,049 - $24,523	22,499 New	22,499 $13,000
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $35,352 - $60,805	-47,136 Closed	0 $0

Q1 2020 May 15, 2020	BUY	$0.33 - $1.62 $15,554 - $76,360	47,136 New	47,136 $45,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $445M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.